Skip to main content

Maternal Short Sleep Duration Linked to Neurodevelopmental Delay in Boys

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 3, 2024.

By Elana Gotkine HealthDay Reporter

THURSDAY, Oct. 3, 2024 -- Maternal short sleep duration (SSD) during midpregnancy is associated with an increased incidence of neurodevelopmental delay in boys, according to a study published online Sept. 26 in the Journal of Clinical Endocrinology & Metabolism.

Lei Zhang, Ph.D., from the School of Public Health at Anhui Medical University in Hefei, China, and colleagues examined the association between SSD in pregnancy and offspring neurodevelopmental delay in a cohort study involving 7,059 mother-child pairs from the Maternal & Infants Health in Hefei cohort. Sleep data during pregnancy were collected at weeks 24 to 28 and 32 to 36. Neurodevelopmental outcomes were assessed from six to 36 months postpartum.

The researchers observed a significant association between mothers with SSD during midpregnancy and neurodevelopmental delay in boys (adjusted hazard ratio, 2.05). In an analysis of cord blood markers, a positive relationship was seen between cord blood serum C-peptide levels and neurodevelopmental delay in offspring (relative risk, 0.04). Cord blood C-peptide mediated 11.05 percent of the association between SSD and neurodevelopmental delay.

"Maternal SSD was positively linked with an increased frequency of neurodevelopmental delay in neonates," the authors write. "We provide new evidence that cord blood serum C-peptide partly mediates the association of SSD in midpregnancy with neurodevelopmental delay in boys."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted October 2024

Read this next

New Mothers Face Significant Loss of Uninterrupted Sleep

THURSDAY, June 12, 2025 -- New mothers face a significant loss of uninterrupted sleep through week 13 postpartum, according to a study presented at SLEEP 2025, the...

Daytime Napping Behaviors in Middle-Aged, Older Adults Impact Mortality Risk

WEDNESDAY, June 11, 2025 -- Certain objectively measured daytime napping behaviors are associated with an increased risk for mortality for middle- to older-aged adults, according...

Doctors Favor CPAP, Patients Favor Tirzepatide for Comorbid Obesity, Sleep Apnea

MONDAY, June 9, 2025 -- Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.